Therapeutic Asset Ratings
7,021 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ETOPOSIDE
Therapy Related Acute Myeloid Leukemia And Myelodysplastic Syndrome
M.D. Anderson Cancer Center
P3
BB
(70)
ETOPOSIDE
T-Cell Childhood Acute Lymphocytic Leukemia
National Cancer Institute (NCI)
P3
BB
(70)
Evomela
Disease Related To Hematopoietic Stem Cell Transplant
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(70)
FILGRASTIM
Acute Undifferentiated Leukemia
Fred Hutchinson Cancer Center
P3
BB
(70)
FILGRASTIM
Acute Promyelocytic Leukemia
Associazione Italiana Ematologia Oncologia Pediatrica
P3
BB
(70)
FILGRASTIM
B-Cell Acute Lymphoblastic Leukemia
University of Washington
P3
BB
(70)
FILGRASTIM
Juvenile Myelomonocytic Leukemia
Masonic Cancer Center, University of Minnesota
P3
BB
(70)
FILGRASTIM
Non-Small Cell Lung Carcinoma
University of California, Irvine
P3
BB
(70)
FILGRASTIM
Recurrent Adult Soft Tissue Sarcoma
University of California, Irvine
P3
BB
(70)
FILGRASTIM
Follicular Lymphoma
Fred Hutchinson Cancer Center
P3
BB
(70)
FILGRASTIM
Relapsed T-Cell Lymphoma
Sichuan University
P3
BB
(70)
FILGRASTIM
Untreated Adult Acute Myeloid Leukemia
City of Hope Medical Center
P3
BB
(70)
Fludarabine
Acute Megakaryoblastic Leukemia
Fred Hutchinson Cancer Center
P3
BB
(70)
Fludarabine
Acute Erythroid Leukemia
Fred Hutchinson Cancer Center
P3
BB
(70)
Fludarabine
Chronic Myeloid Leukemia
Ohio State University Comprehensive Cancer Center
P3
BB
(70)
Fludarabine
Recurrent Childhood Acute Myeloid Leukemia
Joanna Yi
P3
BB
(70)
FLUDROCORTISONE
Advanced Metastatic Castration Resistant Prostate Cancer
Acerand Therapeutics (Hong Kong) Limited
P3
BB
(70)
FLUOROURACILUM
Anal Carcinoma
Federation Francophone de Cancerologie Digestive
P3
BB
(70)
FLUOROURACILUM
Gastroesophageal Junction Adenocarcinoma
Alliance for Clinical Trials in Oncology
P3
BB
(70)
FLUOROURACILUM
Metastatic Malignant Neoplasm
I-Mab Biopharma US Limited
P3
BB
(70)
FLUTICASONE
Multiple Myeloma and Plasma Cell Neoplasm
Roswell Park Cancer Institute
P3
BB
(70)
FLUTICASONE
Recurrent Melanoma
Mayo Clinic
P3
BB
(70)
FULVESTRANT
Hormone Receptor Positive Tumor
Relay Therapeutics, Inc.
P3
BB
(70)
Fulzerasib
Non-Small Cell Lung Carcinoma
Shandong Suncadia Medicine Co., Ltd.
P3
BB
(70)
Giredestrant
Estrogen-Receptor Positive Breast Cancer
Hoffmann-La Roche
P3
BB
(70)
Showing 476 to 500 of 7,021 assets
Previous
Page 20 of 281
Next